Identifying diabetes cases in health administrative databases: a validation study based on a large French cohort

被引:39
作者
Fuentes, Sonsoles [1 ]
Cosson, Emmanuel [2 ,3 ]
Mandereau-Bruno, Laurence [1 ]
Fagot-Campagna, Anne [4 ]
Bernillon, Pascale [1 ]
Goldberg, Marcel [5 ]
Fosse-Edorh, Sandrine [1 ]
机构
[1] SpF, F-94415 St Maurice, France
[2] Paris 13 Univ, Jean Verdier Hosp, AP HP,CRNH IdF,CINFO, Dept Endocrinol Diabetol Nutr,Sorbonne Paris Cite, Bondy, France
[3] Univ Paris 13, Sorbonne Paris Cite, INSERM, UMR U1153,U1125,Inra,Cnam, Bobigny, France
[4] Caisse Natl Assurance Malad, Strategy & Res Dept, Paris, France
[5] INSERM, UMS 011, Populat Based Epidemiol Cohorts Unit, Villejuif, France
关键词
Information systems; Diabetes; Algorithms; Validation studies; CONSTANCES; PREVALENCE; INSURANCE; MORTALITY; MELLITUS; SNIIRAM; BURDEN; FRANCE; TRENDS;
D O I
10.1007/s00038-018-1186-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
ObjectivesIn the French national health insurance information system (SNDS) three diabetes case definition algorithms are applied to identify diabetic patients. The objective of this study was to validate those using data from a large cohort.MethodsThe CONSTANCES cohort (Cohorte des consultants des Centres d'examens de sante) comprises a randomly selected sample of adults living in France. Between 2012 and 2014, data from 45,739 participants recorded in a self-administrated questionnaire and in a medical examination were linked to the SNDS. Two gold standards were defined: known diabetes and pharmacologically treated diabetes. Sensitivity, specificity, positive and negative predictive values (PPV, NPV) and kappa coefficients (k) were estimated.ResultsAll three algorithms had specificities and NPV over 99%. Their sensitivities ranged from 73 to 77% in algorithm A, to 86 and 97% in algorithm B and to 93 and 99% in algorithm C, when identifying known and pharmacologically treated diabetes, respectively. Algorithm C had the highest k when using known diabetes as the gold standard (0.95). Algorithm B had the highest k (0.98) when testing for pharmacologically treated diabetes.ConclusionsThe SNDS is an excellent source for diabetes surveillance and studies on diabetes since the case definition algorithms applied have very good test performances.
引用
收藏
页码:441 / 450
页数:10
相关论文
共 36 条
[1]   The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology [J].
Bezin, Julien ;
Duong, Mai ;
Lassalle, Regis ;
Droz, Cecile ;
Pariente, Antoine ;
Blin, Patrick ;
Moore, Nicholas .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (08) :954-962
[2]   Diabetes mellitus and obesity in the French Caribbean: A special vulnerability for women? [J].
Carrere, Philippe ;
Fagour, Cedric ;
Sportouch, Dan ;
Gane-Troplent, Franciane ;
Helene-Pelage, Jeannie ;
Lang, Thierry ;
Inamo, Jocelyn .
WOMEN & HEALTH, 2018, 58 (02) :145-159
[3]   IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045 [J].
Cho, N. H. ;
Shaw, J. E. ;
Karuranga, S. ;
Huang, Y. ;
Fernandes, J. D. da Rocha ;
Ohlrogge, A. W. ;
Malanda, B. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 138 :271-281
[4]  
Clottey C, 2001, Chronic Dis Can, V22, P67
[5]  
Dart D, 2011, CANADA DIABETES CARE, V34, P898, DOI [10.2337/dc10-1572, DOI 10.2337/DC10-1572]
[6]  
Day HR, 2013, 114 NAT HLTH STAT, P1
[7]   The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach [J].
de Lagasnerie, Gregoire ;
Aguade, Anne-Sophie ;
Denis, Pierre ;
Fagot-Campagna, Anne ;
Gastaldi-Menager, Christelle .
EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2018, 19 (02) :189-201
[8]   Diagnosed and Undiagnosed Diabetes Prevalence by County in the US, 1999-2012 [J].
Dwyer-Lindgren, Laura ;
Mackenbach, Johan P. ;
van Lenthe, Frank J. ;
Flaxman, Abraham D. ;
Mokdad, Ali H. .
DIABETES CARE, 2016, 39 (09) :1556-1562
[9]   Algorithms based on medico-administrative data in the field of endocrine, nutritional and metabolic diseases, especially diabetes [J].
Fosse-Edorh, S. ;
Rigou, A. ;
Morin, S. ;
Fezeu, L. ;
Mandereau-Bruno, L. ;
Fagot-Campagna, A. .
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2017, 65 :S168-S173
[10]   Comorbidities at multiple sclerosis diagnosis [J].
Fromont, Agnes ;
Binquet, Christine ;
Rollot, Fabien ;
Despalins, Romain ;
Weill, Alain ;
Clerc, Laurence ;
Bonithon-Kopp, Claire ;
Moreau, Thibault .
JOURNAL OF NEUROLOGY, 2013, 260 (10) :2629-2637